Search results for "FACTOR"

showing 10 items of 17757 documents

The nicotinic acetylcholine receptor agonist (±)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain

2000

Abstract In a previous work, we showed that acute intermittent nicotine treatment up-regulates the level of fibroblast growth factor-2 (FGF-2) mRNA in brain regions of tel- and mesencephalon of rats suggesting that neuroprotective effect of (−)nicotine may, at least in part, involve an activation of the neuronal FGF-2 signalling. The present experiments were designed to extend the study on the nicotinic receptor mediated up-regulation of FGF-2 mRNA levels to the use of the potent nicotinic acetylcholine receptor (nAChR) agonist (±)-epibatidine. The (±)-epibatidine treatment led to a strong and long lasting up-regulation of FGF-2 mRNA expression in the cerebral cortex, in the hippocampal for…

medicine.medical_specialtyTime FactorsNicotinic acetylcoline receptor agonistPyridinesBlotting WesternNerve Tissue ProteinsNicotinic AntagonistsFibroblast growth factor-2MecamylamineBiologyHippocampusRats Sprague-DawleyNicotineCellular and Molecular NeuroscienceInternal medicineMecamylaminemedicineGlial cell line-derived neurotrophic factorAnimalsGlial Cell Line-Derived Neurotrophic FactorNerve Growth FactorsNicotinic AgonistsRNA MessengerMolecular BiologyIn Situ HybridizationEpibatidineCerebral CortexBrain-derived neurotrophic factorDose-Response Relationship DrugBrain-Derived Neurotrophic FactorBrainBridged Bicyclo Compounds HeterocyclicCorpus StriatumRatsSpecific Pathogen-Free OrganismsNicotinic acetylcholine receptorEndocrinologyNicotinic agonistGene Expression RegulationEpibatidinebiology.proteinFibroblast Growth Factor 2Alpha-4 beta-2 nicotinic receptorFibroblast growth factor receptor-1medicine.drugMolecular Brain Research
researchProduct

Female obesity: short- and long-term consequences on the offspring

2013

The worldwide prevalence of obesity has risen over the past few decades and women are currently more likely than ever to enter pregnancy obese. Pre-pregnancy obesity and excessive gestational weight gain increase miscarriage rates and obstetric and neonatal complications, which result in a lower healthy live birth rate. In addition to its negative consequences for the mother, obesity has been shown to be an important risk factor for chronic illnesses, such as cardiovascular disease, metabolic syndrome and type 2 diabetes in the adolescence and adulthood of the offspring. Moreover, maternal obesity causes psychological problems, physical disabilities and higher healthcare costs. Fetal progra…

medicine.medical_specialtyTime FactorsOffspringEndocrinology Diabetes and MetabolismBirth weightType 2 diabetesManagement of obesityMiscarriageFetal DevelopmentEndocrinologyPregnancyRisk FactorsmedicineHumansObesityPregnancybusiness.industryObstetricsObstetrics and Gynecologymedicine.diseaseObesityPregnancy ComplicationsPrenatal Exposure Delayed EffectsFemaleMetabolic syndromebusinessGynecological Endocrinology
researchProduct

Characterization of choline efflux from the perfused heart at rest and after muscarine receptor activation.

1986

The resting efflux of choline from perfused chicken hearts varied from 0.4 to 2.6 nmol/g min, but was constant for at least 80 min in the individual experiments. The rate of choline efflux was found to be equal to the rate of choline formation in the heart, which, from the following reasons, was essentially due to hydrolysis of choline phospholipids. Cardiac content of choline phospholipids (7,200 nmol/g) was much higher than that of acetylcholine (5.5 nmol/g). Resting release of acetylcholine was 0.016 nmol/g min and, after inhibition of cholinesterase, only about 0.1 nmol/g min. Resting efflux of choline was reduced by mepacrine, a phospholipase A2 inhibitor, by perfusion with a Ca2+-free…

medicine.medical_specialtyTime FactorsOleic AcidsIn Vitro TechniquesCholinechemistry.chemical_compoundInternal medicinemedicineCholineAnimalsMagnesiumPhospholipidsCholinesterasePharmacologyMuscarinebiologyMyocardiumGeneral MedicineIsolated heartMyocardial ContractionReceptors MuscarinicPerfusionEndocrinologychemistryParasympathomimeticsQuinacrinebiology.proteinCalciumEffluxCholine formationReceptor activationChickensAcetylcholinemedicine.drugOleic AcidNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Home treatment of pulmonary embolism: are all the questions answered now after the HOME-PE trial?

2020

medicine.medical_specialtyTime FactorsPhysiologyClinical Decision-MakingRisk AssessmentSeverity of Illness IndexDecision Support TechniquesPredictive Value of TestsRisk FactorsPhysiology (medical)medicineHumansIntensive care medicineLungbusiness.industryLength of StayPrognosismedicine.diseaseHome Care ServicesThrombosisPatient DischargePulmonary embolismmedicine.anatomical_structureHome treatmentPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessCardiovascular Research
researchProduct

Adipose tissue lymphocytes: types and roles

2009

Besides adipocytes, specialized in lipid handling and involved in energy balance regulation, white adipose tissue (WAT) is mainly composed of other cell types among which lymphocytes represent a non-negligible proportion. Different types of lymphocytes (B, alphabetaT, gammadeltaT, NK and NKT) have been detected in WAT of rodents or humans, and vary in their relative proportion according to the fat pad anatomical location. The lymphocytes found in intra-abdominal, visceral fat pads seem representative of innate immunity, while those present in subcutaneous fat depots are part of adaptive immunity, at least in mice. Both the number and the activity of the different lymphocyte classes, except …

medicine.medical_specialtyTime FactorsPhysiologyLymphocyteAdipose tissueWhite adipose tissueBiologyModels BiologicalBiochemistryFat padProinflammatory cytokineMiceImmune systemAdipokinesInternal medicineDiabetes MellitusmedicineAnimalsHumansLymphocytesObesityInflammationInnate immune systemGeneral MedicineAcquired immune systemmedicine.anatomical_structureEndocrinologyAdipose TissueImmune SystemImmunologyJournal of Physiology and Biochemistry
researchProduct

Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rab…

1996

Objective: The complement system has been suggested to play a role in reperfusion injury which may result from an enhanced destruction of myocardial tissue or from an impairment of reflow. We investigated the influence of the C5b-9 complement complex on infarct size, reflow and arrhythmogenesis. Methods: Twenty-eight C6-competent rabbits and 18 rabbits with congenital C6 deficiency were subjected to either 30 min or 2 h of coronary artery occlusion followed by reperfusion. C6 deficiency was confirmed by the complement titration test and immunohistology. The triphenyl tetrazolium chloride method was used to delineate infarct size. Reflow into infarcted areas was evaluated histologically afte…

medicine.medical_specialtyTime FactorsPhysiologyMyocardial InfarctionIschemiaInfarctionMyocardial Reperfusion InjuryComplement Membrane Attack ComplexElectrocardiographyReperfusion therapyPhysiology (medical)Internal medicinemedicineAnimalscardiovascular diseasesComplement Activationbusiness.industryArrhythmias Cardiacmedicine.diseaseImmunohistochemistryComplement C6Complement systemRegional Blood FlowCoronary occlusionNo reflow phenomenoncardiovascular systemCardiologyRabbitsCardiology and Cardiovascular MedicineComplement membrane attack complexbusinessReperfusion injuryCardiovascular Research
researchProduct

Oxygen and substrate deprivation on isolated rat cardiac myocytes : temporal relationship between electromechanical and biochemical consequences

1990

The effects of hypoxia and reoxygenation on action potentials (AP), contractions, and certain biochemical parameters were studied in isolated rat ventricular myocytes in monolayer culture in the presence and absence of glucose. Substrate deprivation alone had no influence on the basal properties. In the presence of glucose, a 4-h hypoxic treatment caused only a moderate decrease in AP amplitude and rate. In substrate-free conditions, hypoxia induced a gradual decline in plateau potential level and in AP duration and rate, followed by rhythm abnormalities and a failure of the electromechanical coupling. Spontaneous AP generation then ceased, and the resting potential decreased with increase…

medicine.medical_specialtyTime FactorsPhysiology[SDV]Life Sciences [q-bio]Action Potentialschemistry.chemical_element030204 cardiovascular system & hematologyBiologyGLYCOSEACIDE LACTIQUEOxygenMembrane PotentialsContractility03 medical and health sciencesAdenosine Triphosphate0302 clinical medicinePhysiology (medical)Internal medicinemedicineAnimalsMyocyteHypoxiaCells Cultured030304 developmental biologyPharmacologyFREQUENCE0303 health sciencesL-Lactate DehydrogenaseMyocardiumRats Inbred StrainsBiological activityGeneral MedicineHypoxia (medical)Myocardial ContractionRatsElectrophysiologyATP[SDV] Life Sciences [q-bio]ElectrophysiologyGlucoseEndocrinologychemistryCell cultureCirculatory systemLactatesBiophysicsRATmedicine.symptom
researchProduct

The induction of hepatic microsomal metabolism in rats following acute administration of a mixture of polybrominated biphenyls.

1976

Abstract Firemaster BP6, a mixture of polybrominated biphenyls (PBBs), was administered to female Sprague-Dawley rats (170–180 g) as a single ip injection at 25 and 150 mg/kg. Other animals received phenobarbital (PB), 3-methylcholanthrene (3MC), or PB and 3MC together. Animals were killed at intervals of 12, 24, 48, 192, and 336 hr after treatment with PBBs, or 24 hr after PB, MC, or PB-MC, and various hepatic microsomal parameters were measured. After 150 mg/kg of PBBs, cytochrome P450 concentrations reached a maximum by 48 hr (225% of control), then remained elevated through 336 hr. A similar pattern of induction was observed for epoxide hydratase and aniline hydroxylase activities. In c…

medicine.medical_specialtyTime FactorsPolybrominated BiphenylsIn Vitro TechniquesToxicologyMixed Function OxygenasesInternal medicinemedicineAnimalsEnzyme inducerAniline HydroxylasePharmacologychemistry.chemical_classificationChromatographybiologyBiphenyl CompoundsBody WeightCytochrome P450MetabolismEthylmorphineRatsEnzymeEndocrinologychemistryLiverEnzyme InductionPhenobarbitalbiology.proteinMicrosomeMicrosomes LiverPhenobarbitalFemalemedicine.drugMethylcholanthreneToxicology and applied pharmacology
researchProduct

Analysis of the sleep period and the amount of habitual snoring in individuals with sleep bruxism

2019

Background The literature does not report any association between habitual snoring and sleep bruxism, but these situations can be a reason for frequent complaints of individuals, impairing the quality of life. This study was performed to investigate the sleep period and amount of habitual snoring in individuals with sleep bruxism observing expiratory, inspiratory, and mixed snoring. Material and Methods A total of 90 individuals were screened and divided into the following groups: with sleep bruxism (n=45) and those without sleep bruxism (n=45). Single night sleep polysomnography was performed to diagnose sleep bruxism, quantify habitual snoring and sleep period. The results were tabulated …

medicine.medical_specialtyTime FactorsPolysomnographyHabitual snoringSleep BruxismPolysomnographyAudiology03 medical and health sciences0302 clinical medicineMultivariate analysis of varianceQuality of lifemedicineHumansSleep periodGeneral DentistrySONOOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryResearchSnoringSignificant difference030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Sleep in non-human animalsstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeSurgerySleep Bruxismbusiness
researchProduct

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-i…

2022

Summary Background Vancomycin is the most widely used antibiotic for neonatal Gram-positive sepsis, but clinical outcome data of dosing strategies are scarce. The NeoVanc programme comprised extensive preclinical studies to inform a randomised controlled trial to assess optimised vancomycin dosing. We compared the efficacy of an optimised regimen to a standard regimen in infants with late onset sepsis that was known or suspected to be caused by Gram-positive microorganisms. Methods NeoVanc was an open-label, multicentre, phase 2b, parallel-group, randomised, non-inferiority trial comparing the efficacy and toxicity of an optimised regimen of vancomycin to a standard regimen in infants aged …

medicine.medical_specialtyTime FactorsPopulationEquivalence Trials as TopicLoading doseArticlelaw.inventionGram-positiveRandomized controlled triallawVancomycinIntensive careInternal medicineIntensive Care Units NeonatalSepsisDevelopmental and Educational PsychologyClinical endpointMedicineHumansDosingeducationInfusions Intravenouseducation.field_of_studybusiness.industryInfant NewbornInfantdosingUnited KingdomAnti-Bacterial AgentsEuropeRegimenTreatment OutcomeSpainRelative riskPediatrics Perinatology and Child Healthsepsibusiness
researchProduct